Amgen's most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $250.00 short put and a strike $245.00 long put offers a potential 34.41% return on risk over the next 6 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $250.00 by expiration. The full premium credit of $1.28 would be kept by the premium seller. The risk of $3.72 would be incurred if the stock dropped below the $245.00 long put strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Amgen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 68.64 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
What Kind Of Shareholders Own Amgen Inc. (NASDAQ:AMGN)?
Thu, 09 Jul 2020 11:34:38 +0000
If you want to know who really controls Amgen Inc. (NASDAQ:AMGN), then you'll have to look at the makeup of its share…
Biotech Stock Roundup: REGN Initiates Coronavirus Study, NVAX Surges & More
Wed, 08 Jul 2020 14:22:02 +0000
The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.
These Dividend Stocks Have Solid Payout Prospects — and a Built-In Exit Strategy
Tue, 07 Jul 2020 21:02:00 +0000
After notching a roughly 18% gain in April and May, the S&P 500 has gained only about 2% since early June. Here are Barron’s picks for S&P 500 stocks with attractive, but not ultrahigh, dividend yields.
The March to Freedom Fund 2nd-Quarter Review
Tue, 07 Jul 2020 19:42:21 +0000
We have publicly tracked our portfolio since 2015, which has beaten the S&P; 500 in terms of total return over this period of time. Most importantly, dividend income continues to grow Continue reading…
Amgen, Inc. (AMGN): Were Hedge Funds Right About This Stock?
Tue, 07 Jul 2020 18:41:47 +0000
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
Also on Market Tamer…
Follow Us on Facebook